Works matching IS 09733930 AND DT 2024 AND VI 44


Results: 124
    2
    3
    4
    5
    6
    8
    9

    Iranian patients with diabetes and COVID-19-associated mucormycosis: Characteristics, manifestations, and mortality risk factors.

    Published in:
    International Journal of Diabetes in Developing Countries, 2024, v. 44, n. 4, p. 704, doi. 10.1007/s13410-024-01309-5
    By:
    • Salehi, Mohammadreza;
    • Esteghamati, Alireza;
    • Khodavaisy, Sadegh;
    • Khajavi Rad, Nasim;
    • Abdollahi, Alireza;
    • Alemzadeh, Sayyed Amirsina;
    • Nasserisina, Sadaf;
    • Tabari, Azin;
    • Pakdel, Farzad;
    • Mohammadi, Saeed;
    • Joorabloo, Neda;
    • Abdorahimi, Mahsa;
    • Shavandi, Mehrdad;
    • Rabizadeh, Soghra
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Empagliflozin combined with short-term intensive insulin therapy improves glycemic variability and 1,5-anhydroglucitol in patients with type 2 diabetes: a randomized clinical trial.

    Published in:
    International Journal of Diabetes in Developing Countries, 2024, v. 44, n. 3, p. 486, doi. 10.1007/s13410-023-01271-8
    By:
    • Hao, Zhihua;
    • Zhao, Yuliang;
    • Zhu, Qiuxiao;
    • Ge, Yanhong;
    • Liu, Zibo;
    • Chen, Yanxia;
    • Jiao, Lijing;
    • Zhao, Xin;
    • Wang, Xing;
    • Wang, Jing;
    • Zhou, Jing;
    • Hao, Huiyao;
    • Hao, Yongmei;
    • Zhou, Hong;
    • Wang, Mian;
    • Zhang, Lihui
    Publication type:
    Article
    49
    50